Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

bb farma s.r.l. - clopidogrel - clopidogrel

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

programmi sanitari integrati s.r.l. - clopidogrel - clopidogrel

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

difarmed sociedad limitada - clopidogrel - clopidogrel

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

farma 1000 s.r.l. - clopidogrel - clopidogrel

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

farmed s.r.l. - clopidogrel - clopidogrel

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

gmm farma s.r.l. - clopidogrel - clopidogrel

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

new pharmashop s.r.l. - clopidogrel - clopidogrel

Europeiska unionen - italienska - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosoppressori - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.